부산대학교 도서관

Objective: Accurate demarcation between multiple endocrine neoplasia, type 1 (MEN1)‐ related primary hyperparathyroidism (MPHPT) and sporadic PHPT (SPHPT) is important to plan the management of primary parathyroid disease and surveillance for other endocrine and nonendocrine tumours. The objective of this study is to compare the clinical, biochemical and radiological features and surgical outcomes in patients with MPHPT versus SPHPT and to identify the predictors of MEN1 syndrome in PHPT. Design, Patients and Measurements: This was an ambispective observationalstudy involving 251 patients with SPHPT and 23 patients with MPHPT evaluated at the endocrine clinic of All India Institute of Medical Sciences, New Delhi, India between January 2015 and December 2021. Results: The prevalence of MEN1 syndrome among patients with PHPT was 8.2% and a genetic mutation was identified by Sanger sequencing in 26.1% of patients with MPHPT. Patients with MPHPT were younger (p <.001), had lower mean serum calcium (p =.01) and alkaline phosphatase (ALP; p =.03) levels and lower bone mineral density (BMD) Z score at lumbar spine (p <.001) and femoral neck (p =.007). The prevalence of renal stones (p =.03) and their complications (p =.006) was significantly higher in MPHPT group. On multivariable analysis, factors predictive of MPHPT were hyperplasia on histopathology [OR 40.1, p <.001], ALP levels within reference range [OR 5.6, p =.02] and lumbar spine BMD [OR 0.39 per unit increase in Z score, p <.001]. Conclusions: Patients with MPHPT have more severe, frequent and early onset of bone and renal involvement despite milder biochemical features. A normal serum ALP, low BMD for age and gender at lumbar spine and histopathology evidence of hyperplasia are predictive factors for MEN1 syndrome in PHPT. [ABSTRACT FROM AUTHOR]